Jade Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Update

SAN FRANCISCO and VANCOUVER, British Columbia, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade” or the “Company”) NASDAQ:JBIO, a clinical-stage biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced financial results for the thir…